Clinical Trials Browser

Phase 2 × Neuroendocrine Tumors × pazopanib × Clear all

NCT01841736 2026-03-18

Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors

Phase 2 Active not recruiting

171 enrolled 15 charts

Neuroendocrine Tumors

NCT01280201 2019-05-29

Pazopanib as Single Agent in Advanced NETs

Phase 2 Completed

44 enrolled 17 charts

Neuroendocrine Tumors

NCT01099540 2015-12-29

Study of Pazopanib Monotherapy in Patients With Unresectable, Metastatic Neuroendocrine Tumor

Phase 2 Completed

Neuroendocrine Tumors